ANI Pharmaceuticals, Inc.
ANIP
$70.70
$0.470.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 108.31M | 92.15M | 78.34M | 40.57M | -10.21M |
| Total Depreciation and Amortization | 85.80M | 89.45M | 91.42M | 91.40M | 84.52M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.26M | 35.09M | 22.59M | 23.80M | 23.72M |
| Change in Net Operating Assets | -37.91M | -8.07M | -7.12M | 14.95M | 41.11M |
| Cash from Operations | 189.47M | 208.61M | 185.23M | 170.72M | 139.14M |
| Capital Expenditure | -16.48M | -17.44M | -13.84M | -14.99M | -13.69M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -8.20M | -401.28M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.47M | -8.36M | -20.49M | -20.41M | -20.98M |
| Cash from Investing | -21.94M | -25.80M | -34.32M | -43.60M | -435.96M |
| Total Debt Issued | -- | -- | -- | 0.00 | 641.25M |
| Total Debt Repaid | -14.22M | -12.19M | -10.16M | -8.12M | -298.59M |
| Issuance of Common Stock | 12.34M | 13.27M | 13.60M | 15.27M | 6.67M |
| Repurchase of Common Stock | -22.22M | -21.96M | -12.21M | -11.92M | -11.55M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -344.00K | -751.00K | -1.16M | -1.56M | -1.63M |
| Other Financing Activities | -106.00K | -26.00K | -26.00K | -3.88M | -61.68M |
| Cash from Financing | -24.55M | -21.65M | -9.94M | -10.22M | 274.47M |
| Foreign Exchange rate Adjustments | -554.00K | 220.00K | -233.00K | 725.00K | 74.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.41M | 161.38M | 140.73M | 117.63M | -22.28M |